Stock COV COVALON TECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Covalon Technologies Ltd.

Equities

COV

CA22282D3022

Market Closed - Toronto S.E.
Other stock markets
 10:42:54 15/05/2024 pm IST 		5-day change 1st Jan Change
1.11 CAD +6.73% Intraday chart for Covalon Technologies Ltd. +4.72% +4.72%
06/03 Transcript : Covalon Technologies Ltd. - Shareholder/Analyst Call
28/02 Covalon Technologies Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
AQ
Covalon Technologies : FY2023 AGM Management Presentation
PU
Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024
AQ
Covalon Announces First Quarter Fiscal 2024 Results
BU
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023
AQ
Covalon Announces Management Changes
AQ
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO
AQ
Covalon's VALGuard Gains Prestigious Recognition in the British Journal of Nursing
AQ
Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing
BU
Covalon Announces Issuance of Deferred Share Units
AQ
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access Annual Scientific Meeting in Portland, OR
AQ
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
BU
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
BU
Covalon Announces Leadership Changes
AQ
Covalon Technologies Ltd. - Life with a Central Line, Key Considerations from the Patient's Perspective
AQ
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective
BU
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
BU
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial Results
AQ
Premier Medical Journal Spotlights Covalon's VALGUARD, A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
AQ
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COV Stock
  4. News Covalon Technologies Ltd.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW